Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study

BACKGROUND AND PURPOSE: Anti-muscle-specific kinase (MuSK) positive myasthenia gravis (MG) is characterized by a high relapsing rate, thus, choosing the appropriate oral drug regimen is a challenge. This study aimed to evaluate the efficacy of oral immunosuppressants (IS) in preventing relapse in Mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ying, Shi, Jiayu, Huang, Yangyu, Li, Ke, Yan, Jingwen, Zhu, Li, Guan, Yuzhou, Cui, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237788/
https://www.ncbi.nlm.nih.gov/pubmed/35775051
http://dx.doi.org/10.3389/fneur.2022.877895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237788/
https://www.ncbi.nlm.nih.gov/pubmed/35775051
http://dx.doi.org/10.3389/fneur.2022.877895

Ejemplares similares